Cancer remains one of the most challenging diseases to treat due to its complexity and tendency to metastasize (spread into or invade, nearby tissues...

Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient’s immune cells to target cancer cells. While successful in some types...

Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer, with a low five-year survival rate of 13%. It is the third largest...

Researchers compare the therapeutic efficacy of risakizumab and ustekinumab for the treatment of moderate-to-severe Crohn’s disease.

A recent study by researchers at the Garvan Institute of Medical Research has uncovered a critical link between gene variants associated with leukemia...

A recent study by scientists at the Garvan Institute of Medical Research has uncovered a surprising connection between certain gene variants...

Researchers at the University of Notre Dame have developed a novel, automated device capable of diagnosing glioblastoma, a fast-growing and incurable...

Pancreatic cancer is an aggressive disease with few available treatments. Thankfully, researchers are hard at work to improve treatment options, and...

In an effort to combat one of the most lethal forms of paediatric brain cancer, researchers at the UCLA Health Jonsson Comprehensive Cancer Center,...

Competitive: Stanford University (US): Cancer Genomics Clinical Research Coordinator Associate The Stanford Cancer Institute (SCI) is one of an elite...